financetom
Business
financetom
/
Business
/
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Jun 16, 2025 5:11 PM

(Reuters) -Eli Lilly ( LLY ) is in advanced talks to acquire gene editing startup Verve Therapeutics ( VERV ) for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Reuters could not immediately verify the report.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
COLUMN-Congo conflict is double trouble for global tin market: Andy Home
COLUMN-Congo conflict is double trouble for global tin market: Andy Home
Mar 19, 2025
LONDON, March 19 (Reuters) - Alphamin Resources' ( AFMJF ) decision to suspend operations at the Bisie tin mine in the Democratic Republic of Congo underscores the fragility of tin's global supply chain. Just as one of the world's largest tin mines in Myanmar shows signs of returning after a prolonged absence, another key mine closes as the M23 rebel...
BlackRock, Allianz Part of Consortium Investing in Germany's Viridium
BlackRock, Allianz Part of Consortium Investing in Germany's Viridium
Mar 19, 2025
11:40 AM EDT, 03/19/2025 (MT Newswires) -- BlackRock ( BLK ) and insurers Allianz and T&D are investing in European life insurance consolidation platform Viridium in a 3.5-billion-euro ($3.81 billion) deal, the companies said in a joint statement. Ownership in Germany-based Viridium will be distributed among consortium members as European buyout firm Cinven exits its investment, with Japan's T&D acquiring...
Signet Jewelers Announces Portfolio Optimization Plan, Issues Upbeat Quarterly Sales Outlook
Signet Jewelers Announces Portfolio Optimization Plan, Issues Upbeat Quarterly Sales Outlook
Mar 19, 2025
11:25 AM EDT, 03/19/2025 (MT Newswires) -- Signet Jewelers ( SIG ) on Wednesday unveiled a new strategy to simplify its brand portfolio and accelerate growth, while the diamond jewelry retailer issued a fiscal first-quarter sales outlook above Wall Street estimates at the midpoint. As part of the strategy, the owner of store chains including Kay Jewelers and Zales will...
Update: GDS Holdings' Shares Fall After Q4 Revenue Misses Analyst Estimates
Update: GDS Holdings' Shares Fall After Q4 Revenue Misses Analyst Estimates
Mar 19, 2025
11:37 AM EDT, 03/19/2025 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph and headline.) GDS Holdings ( GDS ) shares were down nearly 15% in recent Wednesday trading after the company's Q4 revenue missed analyst estimates. The company reported a Q4 income Wednesday of 2.81 renminbi ($0.39) per diluted share, swinging from loss of 2.16...
Copyright 2023-2026 - www.financetom.com All Rights Reserved